219 related articles for article (PubMed ID: 23039932)
1. Genetic schizophrenia risk variants jointly modulate total brain and white matter volume.
Terwisscha van Scheltinga AF; Bakker SC; van Haren NE; Derks EM; Buizer-Voskamp JE; Boos HB; Cahn W; Hulshoff Pol HE; Ripke S; Ophoff RA; Kahn RS;
Biol Psychiatry; 2013 Mar; 73(6):525-31. PubMed ID: 23039932
[TBL] [Abstract][Full Text] [Related]
2. Schizophrenia risk variants modulate white matter volume across the psychosis spectrum: evidence from two independent cohorts.
Oertel-Knöchel V; Lancaster TM; Knöchel C; Stäblein M; Storchak H; Reinke B; Jurcoane A; Kniep J; Prvulovic D; Mantripragada K; Tansey KE; O'Donovan MC; Owen MJ; Linden DE
Neuroimage Clin; 2015; 7():764-70. PubMed ID: 25844328
[TBL] [Abstract][Full Text] [Related]
3. Impact on the Onset of Psychosis of a Polygenic Schizophrenia-Related Risk Score and Changes in White Matter Volume.
Harrisberger F; Smieskova R; Egli T; Simon AE; Riecher-Rössler A; Fusar-Poli P; Papassotiropoulos A; Borgwardt S
Cell Physiol Biochem; 2018; 48(3):1201-1214. PubMed ID: 30045020
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association study of multiplex schizophrenia pedigrees.
Levinson DF; Shi J; Wang K; Oh S; Riley B; Pulver AE; Wildenauer DB; Laurent C; Mowry BJ; Gejman PV; Owen MJ; Kendler KS; Nestadt G; Schwab SG; Mallet J; Nertney D; Sanders AR; Williams NM; Wormley B; Lasseter VK; Albus M; Godard-Bauché S; Alexander M; Duan J; O'Donovan MC; Walsh D; O'Neill A; Papadimitriou GN; Dikeos D; Maier W; Lerer B; Campion D; Cohen D; Jay M; Fanous A; Eichhammer P; Silverman JM; Norton N; Zhang N; Hakonarson H; Gao C; Citri A; Hansen M; Ripke S; ; Dudbridge F; Holmans PA
Am J Psychiatry; 2012 Sep; 169(9):963-73. PubMed ID: 22885689
[TBL] [Abstract][Full Text] [Related]
5. The impact of genome-wide supported schizophrenia risk variants in the neurogranin gene on brain structure and function.
Walton E; Geisler D; Hass J; Liu J; Turner J; Yendiki A; Smolka MN; Ho BC; Manoach DS; Gollub RL; Roessner V; Calhoun VD; Ehrlich S
PLoS One; 2013; 8(10):e76815. PubMed ID: 24098564
[TBL] [Abstract][Full Text] [Related]
6. Polygenic determinants of white matter volume derived from GWAS lack reproducibility in a replicate sample.
Papiol S; Mitjans M; Assogna F; Piras F; Hammer C; Caltagirone C; Arias B; Ehrenreich H; Spalletta G
Transl Psychiatry; 2014 Feb; 4(2):e362. PubMed ID: 24548877
[TBL] [Abstract][Full Text] [Related]
7. Genetic associations of brain structural networks in schizophrenia: a preliminary study.
Jagannathan K; Calhoun VD; Gelernter J; Stevens MC; Liu J; Bolognani F; Windemuth A; Ruaño G; Assaf M; Pearlson GD
Biol Psychiatry; 2010 Oct; 68(7):657-66. PubMed ID: 20691427
[TBL] [Abstract][Full Text] [Related]
8. The association of white matter volume in psychotic disorders with genotypic variation in NRG1, MOG and CNP: a voxel-based analysis in affected individuals and their unaffected relatives.
Cannon DM; Walshe M; Dempster E; Collier DA; Marshall N; Bramon E; Murray RM; McDonald C
Transl Psychiatry; 2012 Oct; 2(10):e167. PubMed ID: 23032943
[TBL] [Abstract][Full Text] [Related]
9. Association of GRM3 polymorphism with white matter integrity in schizophrenia.
Mounce J; Luo L; Caprihan A; Liu J; Perrone-Bizzozero NI; Calhoun VD
Schizophr Res; 2014 May; 155(1-3):8-14. PubMed ID: 24680030
[TBL] [Abstract][Full Text] [Related]
10. The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia.
Lett TA; Chakravarty MM; Felsky D; Brandl EJ; Tiwari AK; Gonçalves VF; Rajji TK; Daskalakis ZJ; Meltzer HY; Lieberman JA; Lerch JP; Mulsant BH; Kennedy JL; Voineskos AN
Mol Psychiatry; 2013 Apr; 18(4):443-50. PubMed ID: 23459466
[TBL] [Abstract][Full Text] [Related]
11. Guided exploration of genomic risk for gray matter abnormalities in schizophrenia using parallel independent component analysis with reference.
Chen J; Calhoun VD; Pearlson GD; Perrone-Bizzozero N; Sui J; Turner JA; Bustillo JR; Ehrlich S; Sponheim SR; Cañive JM; Ho BC; Liu J
Neuroimage; 2013 Dec; 83():384-96. PubMed ID: 23727316
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia.
Ho BC; Wassink TH; Ziebell S; Andreasen NC
Schizophr Res; 2011 May; 128(1-3):66-75. PubMed ID: 21420833
[TBL] [Abstract][Full Text] [Related]
13. Association of genetic variants on 15q12 with cortical thickness and cognition in schizophrenia.
Bakken TE; Bloss CS; Roddey JC; Joyner AH; Rimol LM; Djurovic S; Melle I; Sundet K; Agartz I; Andreassen OA; Dale AM; Schork NJ
Arch Gen Psychiatry; 2011 Aug; 68(8):781-90. PubMed ID: 21810643
[TBL] [Abstract][Full Text] [Related]
14. Relation between variants in the neurotrophin receptor gene, NTRK3, and white matter integrity in healthy young adults.
Braskie MN; Kohannim O; Jahanshad N; Chiang MC; Barysheva M; Toga AW; Ringman JM; Montgomery GW; McMahon KL; de Zubicaray GI; Martin NG; Wright MJ; Thompson PM
Neuroimage; 2013 Nov; 82():146-53. PubMed ID: 23727532
[TBL] [Abstract][Full Text] [Related]
15. Overlapping and segregating structural brain abnormalities in twins with schizophrenia or bipolar disorder.
Hulshoff Pol HE; van Baal GC; Schnack HG; Brans RG; van der Schot AC; Brouwer RM; van Haren NE; Lepage C; Collins DL; Evans AC; Boomsma DI; Nolen W; Kahn RS
Arch Gen Psychiatry; 2012 Apr; 69(4):349-59. PubMed ID: 22474104
[TBL] [Abstract][Full Text] [Related]
16. CNTNAP2 polymorphisms and structural brain connectivity: a diffusion-tensor imaging study.
Clemm von Hohenberg C; Wigand MC; Kubicki M; Leicht G; Giegling I; Karch S; Hartmann AM; Konte B; Friedl M; Ballinger T; Eckbo R; Bouix S; Jäger L; Shenton ME; Rujescu D; Mulert C
J Psychiatr Res; 2013 Oct; 47(10):1349-56. PubMed ID: 23871450
[TBL] [Abstract][Full Text] [Related]
17. The role of the major histocompatibility complex region in cognition and brain structure: a schizophrenia GWAS follow-up.
Walters JT; Rujescu D; Franke B; Giegling I; Vásquez AA; Hargreaves A; Russo G; Morris DW; Hoogman M; Da Costa A; Moskvina V; Fernández G; Gill M; Corvin A; O'Donovan MC; Donohoe G; Owen MJ
Am J Psychiatry; 2013 Aug; 170(8):877-85. PubMed ID: 23903335
[TBL] [Abstract][Full Text] [Related]
18. Variability in working memory performance explained by epistasis vs polygenic scores in the ZNF804A pathway.
Nicodemus KK; Hargreaves A; Morris D; Anney R; ; ; Gill M; Corvin A; Donohoe G
JAMA Psychiatry; 2014 Jul; 71(7):778-785. PubMed ID: 24828433
[TBL] [Abstract][Full Text] [Related]
19. Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders.
Voineskos AN; Lett TA; Lerch JP; Tiwari AK; Ameis SH; Rajji TK; Müller DJ; Mulsant BH; Kennedy JL
PLoS One; 2011; 6(6):e20982. PubMed ID: 21687627
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis and brain imaging data support the involvement of VRK2 (rs2312147) in schizophrenia susceptibility.
Li M; Wang Y; Zheng XB; Ikeda M; Iwata N; Luo XJ; Chong SA; Lee J; Rietschel M; Zhang F; Müller-Myhsok B; Cichon S; Weinberger DR; Mattheisen M; Schulze TG; Martin NG; Mitchell PB; Schofield PR; Liu JJ; Su B;
Schizophr Res; 2012 Dec; 142(1-3):200-5. PubMed ID: 23102693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
